FDA Inspection
Watson Pharma Private Ltd.Watson Pharma Private Ltd. – FDA Inspection, Aug 23, 2019
Record Details
This FDA Inspection record concerns Watson Pharma Private Ltd., with an inspection on August 23, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 448ad421-0bd9-4d5a-8109-44ab5f78d44f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1100283
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Watson Pharma Private Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 25, 2025 | Not classified | Office of Inspections and Investigations | |
| July 29, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 13, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 16, 2017 | Not classified | Office of Inspections and Investigations | |
| May 6, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Watson Pharma Private Ltd.
- FDA Inspection 1282322 - 2025-07-25
- FDA Inspection 1177794 - 2022-07-29
- FDA Inspection 1109471 - 2019-09-13
- FDA Inspection 1020061 - 2017-05-16
- FDA Inspection 1016259 - 2017-05-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.